Rosen G, Loren G J, Brien E W, Ramana L, Waxman A, Lowenbraun S, Eckardt J J, Eilber F, Menendez L, Mirra J M
Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048.
Clin Orthop Relat Res. 1993 Aug(293):302-6.
In 27 patients with extremity lesions (24 osteosarcoma, three malignant fibrous histiocytoma), a notable decrease in thallium-201 uptake was correlated with a good response to preoperative chemotherapy of the primary tumor. A good response is indicated by a greater than 95% tumor necrosis. Serial quantitative thallium-201 uptake of malignant bone tumors in patients receiving preoperative chemotherapy therefore can accurately predict a good histologic response and prognosis. Serial thallium scintigraphy can furthermore identify poor responses within two weeks after the initiation of treatment, or can prompt an early change in preoperative chemotherapy and facilitate limb salvage surgery.
在27例肢体病变患者(24例骨肉瘤,3例恶性纤维组织细胞瘤)中,201铊摄取量显著降低与原发肿瘤术前化疗的良好反应相关。良好反应表现为肿瘤坏死率大于95%。因此,接受术前化疗患者的恶性骨肿瘤的系列定量201铊摄取可以准确预测良好的组织学反应和预后。系列铊闪烁扫描还可以在治疗开始后两周内识别不良反应,或促使术前化疗尽早改变并有利于保肢手术。